SecSonar.com

Jaguar Health, Inc. (JAGX)

Jaguar Health, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Jaguar Health, Inc. (JAGX) is a Biotechnology company based in US with a market capitalization of $211.9K. Revenue declined 1.5% year-over-year and the company generated $5.8M in free cash flow. This page tracks JAGX's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 49 employees · IPO May 12, 2015

Valuation

Valuation & price

$2.91 · as of May 23, 2026 · -96.9% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

—

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$94.50$48.44$2.38Jul 25Dec 25Jul 26Jul 7, 25$88.90Jul 9, 25$92.05Jul 11, 25$94.50Jul 15, 25$84.00Jul 17, 25$81.20Jul 21, 25$84.35Jul 23, 25$83.30Jul 25, 25$78.40Jul 29, 25$76.65Jul 31, 25$71.40Aug 4, 25$75.25Aug 6, 25$78.05Aug 11, 25$75.95Aug 13, 25$90.65Aug 15, 25$73.50Aug 19, 25$67.20Aug 21, 25$63.70Aug 25, 25$62.65Aug 27, 25$61.95Aug 29, 25$57.05Sep 3, 25$58.80Sep 5, 25$61.95Sep 9, 25$67.55Sep 11, 25$71.05Sep 16, 25$68.95Sep 18, 25$66.85Sep 22, 25$71.05Sep 24, 25$75.25Sep 26, 25$75.25Sep 30, 25$81.55Oct 2, 25$77.35Oct 6, 25$76.65Oct 8, 25$75.95Oct 10, 25$72.45Oct 14, 25$74.55Oct 16, 25$74.20Oct 21, 25$69.65Oct 23, 25$69.65Oct 27, 25$71.75Oct 29, 25$72.10Oct 31, 25$67.90Nov 4, 25$58.80Nov 6, 25$59.50Nov 10, 25$58.80Nov 12, 25$61.25Nov 14, 25$62.30Nov 18, 25$58.10Nov 20, 25$43.40Nov 25, 25$43.40Nov 28, 25$47.25Dec 2, 25$40.60Dec 4, 25$38.50Dec 8, 25$38.50Dec 10, 25$46.55Dec 12, 25$47.25Dec 16, 25$43.40Dec 18, 25$39.55Dec 22, 25$41.65Dec 24, 25$39.55Dec 29, 25$36.05Jan 2, 26$34.91Jan 6, 26$39.55Jan 8, 26$37.80Jan 12, 26$29.05Jan 14, 26$26.75Jan 16, 26$50.05Jan 21, 26$28.32Jan 23, 26$26.77Jan 27, 26$24.68Jan 29, 26$24.19Feb 2, 26$22.40Feb 4, 26$20.30Feb 9, 26$23.14Feb 11, 26$21.25Feb 13, 26$22.12Feb 18, 26$21.70Feb 20, 26$21.32Feb 24, 26$25.55Feb 26, 26$29.88Mar 2, 26$28.04Mar 4, 26$22.92Mar 6, 26$20.67Mar 10, 26$16.48Mar 12, 26$19.11Mar 17, 26$16.86Mar 19, 26$14.63Mar 23, 26$13.97Mar 25, 26$14.56Mar 27, 26$11.99Mar 31, 26$12.97Apr 2, 26$14.00Apr 7, 26$14.33Apr 9, 26$13.27Apr 13, 26$13.65Apr 15, 26$15.00Apr 17, 26$13.86Apr 22, 26$14.34Apr 24, 26$13.57Apr 28, 26$8.44Apr 30, 26$6.96May 4, 26$3.25May 6, 26$2.82May 8, 26$3.00May 12, 26$3.25May 14, 26$3.94May 18, 26$3.70May 20, 26$3.67May 22, 26$2.91May 28, 26$3.29Jun 1, 26$3.27Jun 3, 26$2.92Jun 5, 26$2.80Jun 9, 26$2.82Jun 11, 26$2.82Jun 15, 26$2.47Jun 17, 26$2.38Jun 22, 26$2.61Jun 24, 26$2.68Jun 26, 26$3.01Jul 2, 26$2.81
$2.2552-week range$94.50
Loading valuation history…

Fundamentals

Key fundamentals

$211.9K

Market cap

-1.5%

Revenue growth (YoY)

67.2%

Gross margin

$5.8M

Free cash flow (USD)

$42.6M

Net debt

691.9%

Share dilution

0/4

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$141.5KFY 2017$4.4MFY 2018$4.4MFY 2019$5.8MFY 2020$9.4MFY 2021$4.3MFY 2022$12.0MFY 2023$9.8MFY 2024$11.7MFY 2025$11.5M
$141.5K$11.5M

Free cash flow by year

2016 → 2025

FY 2016$-14.5MFY 2017$-9.8MFY 2018$-22.7MFY 2019$-20.5MFY 2020$-15.3MFY 2021$-35.0MFY 2022$-34.8MFY 2023$-33.2MFY 2024$-29.6MFY 2025$5.8M
-$14.5M$5.8M

Gross margin by year

2021 → 2025

FY 202146.2%FY 202283.1%FY 202379.1%FY 202483.3%FY 202567.2%
46.2%67.2%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last reported: May 20, 2026 (EPS $-13.60)

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventPreferred Stock ConversionJul 1, 2026Filing
  • 8-K eventManufacturing Agreement AmendmentJun 25, 2026Filing
  • 8-K eventStrategic Alternatives ExplorationJun 22, 2026Filing
  • 8-K eventStrategic Alternatives ExplorationJun 22, 2026Filing
  • 8-K eventRoyalty Interest AmendmentsJun 18, 2026Filing
  • 8-K eventCommon Stock Purchase AgreementJun 11, 2026Filing
  • 8-K eventAnnual Meeting ResultsJun 8, 2026Filing
  • 8-K eventEquity Exchange AgreementJun 2, 2026Filing
  • 8-K eventCompliance with Nasdaq RuleMay 27, 2026Filing
  • 8-K eventStock Exchange AgreementMay 22, 2026Filing

Questions

Frequently asked questions

What is Jaguar Health, Inc.'s market cap?

Jaguar Health, Inc. (JAGX) has a market capitalization of $211.9K.

What is JAGX's P/E ratio?

A meaningful P/E ratio is not available for JAGX — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

When did Jaguar Health, Inc. last report earnings?

JAGX last reported earnings on May 20, 2026; the next date is not yet scheduled.

Are insiders buying JAGX stock?

SEC Form 4 filings show no open-market insider buys at Jaguar Health, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

GRI

GRI Bio, Inc.

$189.5K

NXTS

N2OFF, Inc.

$333.3K

PPBT

Purple Biotech Ltd.

$396K

ONCO

Onconetix, Inc.

$400.8K

ADTX

Aditxt, Inc.

$4K

SPRC

SciSparc Ltd.

$523.4K

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.